Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00755_DB01029_nanopub.RAeLREOxyWMmQMLbtBE34Tqr2Qyim19brI1m5X0PtZ9QI#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00755_DB01029 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00755_DB01029 label "DDI between Tretinoin and Irbesartan - The moderate CYP2C8 inhibitor, Irbesartan, may decrease the metabolism and clearance of oral Tretinoin. Monitor for changes in Tretinoin effectiveness and adverse/toxic effects if Irbesartan is initiated, discontinued to dose changed. [drugbank_resource:DB00755_DB01029]" assertion.
- drugbank_resource:DB00755_DB01029 identifier "drugbank_resource:DB00755_DB01029" assertion.
- drugbank_resource:DB00755_DB01029 title "DDI between Tretinoin and Irbesartan - The moderate CYP2C8 inhibitor, Irbesartan, may decrease the metabolism and clearance of oral Tretinoin. Monitor for changes in Tretinoin effectiveness and adverse/toxic effects if Irbesartan is initiated, discontinued to dose changed." assertion.
- drugbank:DB01029 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00755_DB01029 assertion.
- drugbank:DB00755 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00755_DB01029 assertion.